• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Diabetes News Quiz

News
Poll

3. In a new study, researchers investigated whether the Diabetes Prevention Program lifestyle intervention changed time spent being sedentary and the effect of sedentary time on diabetes development. The intervention was effective at reducing sedentary time.

 

Which of the following is the most likely finding about the effect of sedentary time on diabetes development?

A. Each hour spent watching TV daily increases the risk of diabetes by 3.4%.
B. Each hour spent watching TV daily increases the risk of diabetes by 12.6%.
C. Sedentary time has no effect on diabetes development.
Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
Smoking Linked to Increased Risk of All Subtypes of Type 2 Diabetes / image credit Karolinska Institutet

Smoking Linked to Increased Risk of All Subtypes of Type 2 Diabetes

Grace Halsey
September 16th 2025
Article

EASD 2025: The risk of developing the 4 primary subtypes of T2D was increased by as much as 3-fold and was not dependent on duration of smoking behavior.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease

Approximately Half of People with Diabetes Worldwide Do Not Know They Have the Disease: GBD Analysis

Grace Halsey
September 10th 2025
Article

Nor does receiving a diabetes diagnosis guarantee optimal management as just one-fifth of people treated for the disease reached glycemic control in 2023.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial

Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial

Sydney Jennings
August 26th 2025
Article

Patients taking orforglipron achieved significant weight loss, hemoglobin A1c reduction, and cardiometabolic benefits in the phase 3 ATTAIN-2 study, supporting upcoming global regulatory submissions.

FDA Clears First Over-The-Counter CGM for Weight Management From Signos / image credit ©lukszczepanski/stock.adobe.com

Signos Wins Clearance for First Over-The-Counter CGM for Weight Management

Grace Halsey
August 25th 2025
Article

The combination of the Dexcom Stelo glucose biosensor with an AI platform provides real-time data on how food, exercise, stress, and sleep affect the body.

© 2025 MJH Life Sciences

All rights reserved.